ACM
BIOR

Athyrium Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Athyrium Capital Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.48M Hold
1,092,976
– – 63.12% 1
2024
Q2 		$7.21M Hold
1,092,976
– – 21.51% 2
2024
Q1 		$12M Hold
1,092,976
– – 16.52% 2
2023
Q4 		$14.8M Hold
1,092,976
– – 21.44% 2
2023
Q3 		$23.7M Buy
1,092,976
+923,528
+545% +$29.6M 20.89% 3
2023
Q2 		$6.52M Hold
169,448
– – 4.23% 6
2023
Q1 		$4.69M Hold
169,448
– – 1.68% 8
2022
Q4 		$5.58M Buy
169,448
+50,025
+42% +$3.65M 2.34% 10
2022
Q3 		$14.5M Hold
119,423
– – 5.42% 7
2022
Q2 		$20.9M Hold
119,423
– – 8.79% 3
2022
Q1 		$34.6M Hold
119,423
– – 12.31% 3
2021
Q4 		$62.4M Sell
119,423
-26,165
-18% -$18.8M 22.25% 3
2021
Q3 		$55.3M Hold
145,588
– – 35.09% 1
2021
Q2 		$130M Buy
145,588
+37,461
+35% +$28.6M 54.17% 1
2021
Q1 		$129M Hold
108,127
– – 65.06% 1
2020
Q4 		$144M Buy
+108,127
New +$159M 69.16% 1

Other funds holding BIOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Athyrium Capital Management's BIOR Position: Q3 2024 in Review

Athyrium Capital Management held its Biora Therapeutics, Inc. Common Stock (BIOR) position steady in Q3 2024 at 1,092,976 shares worth $5.48M. The position accounts for 63.12% of the portfolio, ranked #1.

Athyrium Capital Management first reported a position in BIOR in Q4 2020 and has held it in 16 quarters since. The position peaked at $144M in Q4 2020. 20 funds tracked by Wall St. Rank hold BIOR as of Q3 2024.

  • Athyrium Capital Management held 1,092,976 shares of Biora Therapeutics, Inc. Common Stock worth $5.48M as of Q3 2024.
  • Athyrium Capital Management left its Biora Therapeutics, Inc. Common Stock share count unchanged in Q3 2024.
  • Biora Therapeutics, Inc. Common Stock made up 63.12% of Athyrium Capital Management's portfolio in Q3 2024, its #1 holding.
  • Athyrium Capital Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and has held it in 16 quarters since.
  • Athyrium Capital Management's Biora Therapeutics, Inc. Common Stock position peaked at $144M in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Athyrium Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.